12:54 PM
 | 
Dec 19, 2017
 |  BC Innovations  |  Distillery Therapeutics

Cardiovascular

INDICATION: Organ damage

Mouse studies suggest inhibiting CDKN1A could help treat cardiac injury. In cardiac tissue from a neonatal mouse model of surgical resection-induced cardiac injury, levels of CDKN1A were lower in...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >